sdLDL

Small Dense LDL (sdLDL) is a subfraction of low-density lipoprotein particles characterized by their smaller size and higher density. These particles are more atherogenic due to their ability to penetrate the endothelial layer of arteries more easily and their susceptibility to oxidation. Clinically, sdLDL is considered an emerging risk factor for atherosclerotic cardiovascular disease (ASCVD). Researchers have found that sdLDL levels are strongly associated with ASCVD events, even when traditional lipid markers like LDL-C and ApoB are accounted for. This makes sdLDL a valuable biomarker for refining cardiovascular risk assessments. In the context of athletic performance and biohacking, sdLDL is of interest due to its potential implications for cardiovascular health and longevity. Elevated sdLDL levels may indicate a higher risk of cardiovascular events, which could impact an individual's ability to maintain peak physical performance and overall health. However, the clinical utility of sdLDL is still largely confined to research settings due to the lack of standardized measurement methods and cost-effectiveness. Researchers observed that various analytical methods exist for sdLDL determination, such as ultracentrifugation and nuclear magnetic resonance, but no gold standard has been established. Confounding factors include metabolic syndrome, diabetes, and hypercholesterolemia, which can alter sdLDL levels. Additionally, fasting status may affect sdLDL measurements, although this is not universally required for testing.